FDA Grants NeoVista's Request To Utilize Novel Wet AMD Treatment In Compassionate Case (Medical News Today)
NeoVista, Inc., announced that the U.S. Food and Drug Administration (FDA) had approved the company's "compassionate case" waiver to utilize its novel wet age-related macular degeneration (AMD) treatment on a patient with an advanced form of the disease who did not meet criteria for inclusion into current NeoVista investigational treatment protocols.

FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, BOOSTRIX(R), For Adults (Medical News Today)
GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX(R) [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 19-64 years of age.

Wary FDA, Others Taking Time With Drug Reviews (TheStreet.com)
Fitch Ratings says new drug applications faced longer review periods at the FDA and other regulatory agencies during the third quarter, creating a logjam of potential approvals.